IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G
暂无分享,去创建一个
[1] L. Björck,et al. Proteolysis and its regulation at the surface of Streptococcus pyogenes , 2002, Molecular microbiology.
[2] J. Musser,et al. Evasion of human innate and acquired immunity by a bacterial homolog of CD11b that inhibits opsonophagocytosis , 2001, Nature Medicine.
[3] M. Wessels,et al. Absence of a Cysteine Protease Effect on Bacterial Virulence in Two Murine Models of Human Invasive Group A Streptococcal Infection , 2001, Infection and Immunity.
[4] A. Olsén,et al. Effect of SpeB and EndoS from Streptococcus pyogenes on Human Immunoglobulins , 2001, Infection and Immunity.
[5] A. Olsén,et al. EndoS, a novel secreted protein from Streptococcus pyogenes with endoglycosidase activity on human IgG , 2001, The EMBO journal.
[6] Magnus Rasmussen,et al. Improved Pattern for Genome-Based Screening Identifies Novel Cell Wall-Attached Proteins in Gram-Positive Bacteria , 2001, Infection and Immunity.
[7] Bruce A. Roe,et al. Complete genome sequence of an M1 strain of Streptococcus pyogenes , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[8] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[9] J. Musser,et al. Identification and Immunogenicity of Group AStreptococcus Culture Supernatant Proteins , 2000, Infection and Immunity.
[10] Malak Kotb,et al. Inverse Relation between Disease Severity and Expression of the Streptococcal Cysteine Protease, SpeB, among Clonal M1T1 Isolates Recovered from Invasive Group A Streptococcal Infection Cases , 2000, Infection and Immunity.
[11] D. Bessen,et al. Role for a secreted cysteine proteinase in the establishment of host tissue tropism by group A streptococci , 2000, Molecular microbiology.
[12] M. Cunningham,et al. Pathogenesis of group A streptococcal infections. , 2000, Clinical microbiology reviews.
[13] H. Goossens,et al. Molecular characterisation of group A streptococci from invasive and non-invasive disease episodes in Belgium during 1993-1994. , 2000, Journal of medical microbiology.
[14] J. Musser,et al. Crystal structure of the zymogen form of the group A Streptococcus virulence factor SpeB: an integrin-binding cysteine protease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[15] William Wiley Navarre,et al. Surface Proteins of Gram-Positive Bacteria and Mechanisms of Their Targeting to the Cell Wall Envelope , 1999, Microbiology and Molecular Biology Reviews.
[16] M. Wessels,et al. Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection. , 1998, The Journal of clinical investigation.
[17] J. Musser,et al. Genetic Inactivation of an Extracellular Cysteine Protease (SpeB) Expressed by Streptococcus pyogenes Decreases Resistance to Phagocytosis and Dissemination to Organs , 1998, Infection and Immunity.
[18] L. Björck,et al. Streptococcal Protein H Forms Soluble Complement-activating Complexes with IgG, but Inhibits Complement Activation by IgG-coated Targets* , 1997, The Journal of Biological Chemistry.
[19] J. Musser,et al. Inactivation of Streptococcus pyogenes extracellular cysteine protease significantly decreases mouse lethality of serotype M3 and M49 strains. , 1997, The Journal of clinical investigation.
[20] M. Chaussee,et al. Temporal production of streptococcal erythrogenic toxin B (streptococcal cysteine proteinase) in response to nutrient depletion , 1997, Infection and immunity.
[21] A. M. Marciel,et al. Activation of a 66-kilodalton human endothelial cell matrix metalloprotease by Streptococcus pyogenes extracellular cysteine protease , 1996, Infection and immunity.
[22] J. Ferretti,et al. Physical and genetic chromosomal map of an M type 1 strain of Streptococcus pyogenes , 1996, Journal of bacteriology.
[23] L. Björck,et al. Streptococcal cysteine proteinase releases kinins: a virulence mechanism , 1996, The Journal of experimental medicine.
[24] N. Curtis. INVASIVE GROUP A STREPTOCOCCAL INFECTION , 1996 .
[25] D L Stevens,et al. Streptococcal infections of skin and soft tissues. , 1996, The New England journal of medicine.
[26] L. Björck,et al. Biological properties of a Streptococcus pyogenes mutant generated by Tn916 insertion in mga. , 1995, Microbial pathogenesis.
[27] L. Björck,et al. Structure and stability of protein H and the M1 protein from Streptococcus pyogenes. Implications for other surface proteins of gram-positive bacteria. , 1995, Biochemistry.
[28] D. Stevens. Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment. , 1995, Emerging infectious diseases.
[29] L. Björck,et al. Streptococcal Cysteine Proteinase Releases Biologically Active Fragments of Streptococcal Surface Proteins (*) , 1995, The Journal of Biological Chemistry.
[30] J. Musser,et al. Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: recent intercontinental spread of a subclone causing episodes of invasive disease , 1995, Infection and immunity.
[31] J. Musser,et al. Non‐congruent relationships between variation in emm gene sequences and the population genetic structure of group A streptococci , 1994, Molecular microbiology.
[32] J Cooney,et al. M1 protein and protein H: IgGFc- and albumin-binding streptococcal surface proteins encoded by adjacent genes. , 1994, The Biochemical journal.
[33] L. Björck,et al. Protein H — a surface protein of Streptococcus pyogenes with separate binding sites for lgG and albumin , 1994, Molecular microbiology.
[34] M. Boyle,et al. Association of type II immunoglobulin G-binding protein expression and survival of group A streptococci in human blood , 1993, Infection and immunity.
[35] J. Musser,et al. Cleavage of interleukin 1 beta (IL-1 beta) precursor to produce active IL-1 beta by a conserved extracellular cysteine protease from Streptococcus pyogenes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[36] L. Björck,et al. Convergent evolution among immunoglobulin G-binding bacterial proteins. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[37] S. Holm,et al. Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988-1989. , 1992, The Journal of infectious diseases.
[38] E. Myers,et al. Basic local alignment search tool. , 1990, Journal of molecular biology.
[39] L. Björck,et al. Protein H--a novel IgG binding bacterial protein. , 1990, Molecular immunology.
[40] L. Björck,et al. The gene sequence and some properties of protein H. A novel IgG-binding protein. , 1990, Journal of immunology.
[41] V. Fischetti,et al. Streptococcal M protein: molecular design and biological behavior , 1989, Clinical Microbiology Reviews.
[42] I. Olafsson,et al. Bacterial growth blocked by a synthetic peptide based on the structure of a human proteinase inhibitor , 1989, Nature.
[43] D. Tenen,et al. Amino acid sequence of the alpha subunit of human leukocyte adhesion receptor Mo1 (complement receptor type 3) , 1988, The Journal of cell biology.
[44] M. Caparon,et al. Identification of a gene that regulates expression of M protein, the major virulence determinant of group A streptococci. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[45] A. Barrett,et al. Identification of the probable inhibitory reactive sites of the cysteine proteinase inhibitors human cystatin C and chicken cystatin. , 1987, The Journal of biological chemistry.
[46] P. Cleary,et al. Cloning and expression of the gene for an immunoglobulin G Fc receptor protein from a group A streptococcus , 1987, Infection and immunity.
[47] P. Cleary,et al. Mechanism of action of the group A streptococcal C5a inactivator. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[48] D. Burton. Immunoglobulin G: functional sites. , 1985, Molecular immunology.
[49] L. Björck,et al. Purification and some properties of streptococcal protein G, a novel IgG-binding reagent. , 1984, Journal of immunology.
[50] K. Reis,et al. Streptococcal Fc receptors. I. Isolation and partial characterization of the receptor from a group C streptococcus. , 1984, Journal of immunology.
[51] E. Shaw,et al. Peptidyl diazomethyl ketones are specific inactivators of thiol proteinases. , 1981, The Journal of biological chemistry.
[52] A. Forsgren,et al. “Protein A” from S. Aureus I. Pseudo-Immune Reaction with Human γ-Globulin , 1966 .
[53] R. Lancefield. Current knowledge of type-specific M antigens of group A streptococci. , 1962, Journal of immunology.
[54] S. Elliott. A PROTEOLYTIC ENZYME PRODUCED BY GROUP A STREPTOCOCCI WITH SPECIAL REFERENCE TO ITS EFFECT ON THE TYPE-SPECIFIC M ANTIGEN , 1945, The Journal of experimental medicine.
[55] H. Herwald,et al. Streptococcal cysteine proteinase releases kinins : a novel virulence mechanism , 2003 .
[56] D. Stevens. Streptococcal toxic shock syndrome associated with necrotizing fasciitis. , 2000, Annual review of medicine.
[57] K. S. Sriprakash,et al. Streptococcus pyogenes strains containing emm12 and emm55 possess a novel gene coding for distantly related SIC protein. , 1999, Microbial pathogenesis.
[58] S. Brunak,et al. SHORT COMMUNICATION Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites , 1997 .
[59] R. Isberg,et al. Binding and internalization of microorganisms by integrin receptors. , 1994, Trends in microbiology.